HRMY 8-K 2026-11-04

Harmony Biosciences Holdings, Inc. (HRMY) 8-K dated 2026-11-04 — accession 0001104659-26-122377.

Harmony Biosciences Holdings, Inc. (HRMY) is a biotechnology company listed on NASDAQ.

Harmony Biosciences Holdings, Inc. filed a 8-K on 2026-11-04. Accession 0001104659-26-122377.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HRMY revenue for 2025-12-31 was $868.5M. Net income was $158.7M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 12.0.

Not investment advice. The HRMY SEC hub lists recent forms. The stock page is the research view.